SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-20-014322
Filing Date
2020-10-06
Accepted
2020-10-06 07:39:46
Documents
2
Period of Report
2020-10-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_160198437422789.html 3  
1 FORM 3 wf-form3_160198437422789.xml 3 2311
2 POA LAWTON poalawton.htm EX-24 3701
  Complete submission text file 0001628280-20-014322.txt   7578
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 39 ROBINSON ROAD LEXINGTON MA 02420
Business Address
Lawton Alison Frances (Reporting) CIK: 0001542650 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38295 | Film No.: 201225580